GS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Goldman Sachs (GS) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the stock shows some positive technical indicators and has potential long-term growth catalysts, the mixed analyst ratings, balanced congressional trading activity, and lack of strong proprietary trading signals suggest a cautious approach. Holding the stock or waiting for a more favorable entry point is recommended.
The technical indicators for GS are moderately positive. The MACD is above zero and expanding positively, indicating bullish momentum. The RSI is neutral at 69.292, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 1108.678 and 1138.169, while support levels are at 1013.209 and 983.718. However, the stock's price change is minimal, with a slight pre-market gain of 1.49% and a regular market decline of -0.23%.
The Federal Reserve's decision to keep rates steady is expected to benefit investment banks like Goldman Sachs by enhancing IPO market activity and potentially widening profit margins.
Strong trading performance is anticipated for Q2, with analysts expecting it to be the second-best revenue quarter ever.
Positive MACD and bullish moving averages indicate some technical strength.
Mixed analyst ratings with several firms lowering price targets, citing slower revenue growth and macroeconomic risks.
Balanced congressional trading activity, with no clear bullish signal from influential figures.
Lack of strong proprietary trading signals (AI Stock Picker and SwingMax) for GS.
No financial data available for the latest quarter. However, analysts have noted strong activity in investment banking during Q1, with expectations of a durable rebound in this segment.
Analyst ratings are mixed. JPMorgan raised the price target to $900 but maintained a Neutral rating. Citi and UBS also kept Neutral ratings with adjusted price targets of $930. Argus and Jefferies maintained Buy ratings with price targets of $1066 and $1049, respectively. BofA and Morgan Stanley lowered price targets but kept Buy and Equal Weight ratings. HSBC issued a Reduce rating with a price target of $729. The consensus reflects cautious optimism but highlights risks and slower revenue growth.
